Skip to main content

Find Clinical Trials

Home
Conditions
Breast Cancer Metastatic

Clinical trial condition

Breast Cancer Metastatic

Explore clinical trials studying Breast Cancer Metastatic. Study availability and eligibility vary by location and protocol.

73 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Breast Cancer Metastatic trial results

Completed

Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.

NCT05155566

Conditions: Breast Cancer Metastatic, Breast Diseases, Breast Neoplasms, +4 more
Locations: Pfizer country office Buenos Aires, Argentina

Adelphi Mill, Bollington, Cheshire, SK10 5JB, UK Bollington, Chesshire, United Kingdom

View Trial Details

Completed

Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer

NCT04350021

Conditions: Breast Cancer Metastatic, Chemotherapy Effect
Locations: Sahlgrenska University Hospital Gothenburg, Västra Götaland County, Sweden

View Trial Details

Completed

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

NCT04483505

Conditions: Breast Cancer Metastatic, Hormone Receptor Positive Malignant Neoplasm of Breast
Locations: Institut Català d'oncologia - Hospital Duran I Reynals L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain

Hospital Quirónsalud Madrid Pozuelo de Alarcón, Madrid, Spain

Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain

View Trial Details

Completed

Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer

NCT03555877

Conditions: Breast Cancer Metastatic
Locations: Studienzentrum Onkologie Ravensburg Ravensburg, Germany

View Trial Details

Completed

Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients

NCT05301010

Conditions: Breast Cancer Female, Breast Cancer Metastatic, Breast Cancer Recurrent
Locations: 19-8 Hospital Hanoi, Vietnam

HCMC Oncology Hospital Ho Chi Minh City, Vietnam

View Trial Details

Completed

Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer

NCT05609903

Conditions: Breast Cancer Metastatic, Breast Diseases, Breast Neoplasms, +4 more
Locations: Policlinico A. Gemelli - IRCCS Roma, RM, Italy

View Trial Details

Completed

The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study

NCT05463276

Conditions: Breast Cancer, Breast Cancer Invasive, Breast Cancer Metastatic, +7 more
Locations: Sindh Institute of Urology and Transplantation Karachi, Sindh, Pakistan

View Trial Details

Completed

Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.

NCT05301530

Conditions: Breast Cancer Female, Breast Cancer Metastatic, Breast Cancer Recurrent
Locations: 19-8 Hospital Hanoi, Vietnam

HCMC Oncology Hospital Ho Chi Minh City, Vietnam

View Trial Details

Completed

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

NCT03045653

Conditions: Breast Cancer Metastatic, Breast Diseases, Breast Neoplasms, +4 more
Locations: Sun Yat-sen University, Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients

NCT02511639

Conditions: Breast Cancer Metastatic
Locations: Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona Ancona, AN, Italy

Ospedale Papa Giovanni XXIII Bergamo, Bg, Italy

Policlinico Sant'Orsola Malpighi Bologna, BO, Italy

ASL Brindisi "Antonio Perrini" Brindisi, BR, Italy

View all 16 locations

View Trial Details